UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                 SCHEDULE 14D-9

       Solicitation/Recommendation Statement Pursuant to Section 14(d)(4)
                     of the Securities Exchange Act of 1934

                            BellaVista Capital, Inc.
                            (Name of Subject Company)

                            BellaVista Capital, Inc.
                     (Name(s) of Person(s) Filing Statement)

                                  Common Stock
                         (Title of Class of Securities)

                                      None
                      (CUSP Number of Class of Securities)

                            Michael Rider, President
                            BellaVista Capital, Inc.
                          420 Florence Street Suite 200
                               Palo Alto, CA 94301
                                 (650) 328-3060

                                    Copy to:

                                 Paul Derenthal
                           Derenthal & Dannhauser LLP
                            One Post Street Suite 575
                             San Francisco, CA 94104
                                 (650) 328-3060


    (Name, address (including zip code) and telephone number (including area
code) of person(s) authorized to receive notices and communications on behalf of
                        the person(s) filing statement)

[ ] Check the box if the filing  relates  solely to  preliminary  communications
made before the commencement of a tender offer.







ITEM 1.  SUBJECT COMPANY INFORMATION.

     The name of the subject  company is  BellaVista  Capital,  Inc., a Maryland
corporation  (the "Company").  The address of the principal  executive office of
the Company is 420 Florence Street Suite 200, Palo Alto,  California  94301. The
Company's telephone number at that address is (650) 328-3060.

     The title of the class of equity securities to which this statement relates
is the Company's  Common Stock,  par value $0.01 per share (the  "Shares").  The
number of Shares outstanding as of August 20, 2007 was 13,959,452.

ITEM 2.  IDENTITY AND BACKGROUND OF FILING PERSON.

     This Schedule  14D-9 is being filed by the Company.  The name,  address and
telephone number of the Company are set forth in Item 1 above.

     This  Schedule  14D-9  relates to a tender  offer (the "MPF  Offer")  dated
September  21, 2007 by MPF-NY 2007,  LLC; MPF Badger  Acquisition  Co., LLC; MPF
DeWaay Premier Fund 3, LLC;  MacKenzie  Patterson Special Fund 5, LLC; MacKenzie
Patterson  Special Fund 6, LLC;  MacKenzie  Patterson Special Fund 6-A, LLC; MPF
DeWaay Fund 5, LLC; MPF  Flagship  Fund 13, LLC; MPF Senior Note Program II, LP;
MPF  Acquisition Co. 3, LLC; and MP Value Fund 5, LLC  (collectively,  "MPF") to
purchase up to 750,000 Shares at a purchase price equal to $1.75 per Share, less
the amount of any dividends  declared or made with respect to the Shares between
September  21,  2007 and October 31, 2007 or a later date to which the MPF Offer
may be extended,  upon the terms and subject to the  conditions  set forth in an
MPF Offer to Purchase dated September 21, 2007.

     As set forth in MPF's  Schedule TO filed with the  Securities  and Exchange
Commission (the "SEC") on September 21, 2007, the principal executive offices of
MPF are located at 1640 School Street, Moraga, California 94556.

ITEM 3.  PAST CONTACTS, TRANSACTIONS, NEGOTIATIONS AND AGREEMENTS.

     Not applicable.

ITEM 4.  THE SOLICITATION OR RECOMMENDATION.

     The Company's  Board of Directors  (the "Board") has reviewed and carefully
considered  the MPF Offer and has concluded that the  consideration  provided by
the MPF Offer is inadequate to the shareholders of the Company. The MPF Offer is
the sixth in a sequential  series of tender  offers (five prior offers have been
made,  in June and  October,  2005,  April  and  October  2006,  and June  2007,
respectively).  All have been made at prices which are significantly  below what
the Company has  estimated  to be the net  realizable  value of its assets.  The
$1.75 per Share offer price is $0.50 per Share less than  offered by MPF in June
2007,  while the Company's  estimate of the  realizable  value of its assets (on
which MPF says it has relied in determining  its offer price)  decreased by only
$0.16 per Share since that date. There is no market for the Shares and there can
be no assurance  as to when or whether the  Shareholders  will  realize  amounts
equal to the  estimated  asset values for the Shares.  As the Company  announced
that it did not intend to make any redemptions through at least the end of 2008,
the MPF tender offers, including the current MPF Offer, and the Company's tender
offers in response  to those MPF  offers,  have  provided  the only  significant
opportunity for liquidity to the Shareholders  during the past two years.  While
the Board  believes  that the price  offered by MPF is  substantially  below the
value of the Shares,  they have  nevertheless  concluded  that it will be in the
best interest of the Company and its  Shareholders  to make a competing offer to
acquire  up to  750,000  Shares  at a price of $2.00  per  Share  (the  "Company
Offer").  Though  the  Company  Offer  price  is also  substantially  below  the
estimated asset value per Share, the Company  recognizes that some  Shareholders
may have a pressing need or desire to liquidate  their Shares at this time.  The
Company  believes  that  it is in the  best  interest  of the  Company  and  its
Shareholders  to provide these  Shareholders  an  opportunity  to liquidate at a
price in excess of the MPF Offer price.

     The Board unanimously recommends that shareholders reject the MPF Offer and
not tender  their  Shares.  Shareholders  are urged to  carefully  consider  the
factors  set forth  herein  and the  information  set forth in the Letter to the
Shareholders, dated as of October 1, 2007, a copy of which is attached hereto as




Exhibit (a)(1) and incorporated  herein by reference.  The Board remains neutral
with  respect to the Company  Offer and does not make any  recommendation  as to
whether you should tender or refrain from  tendering  your shares in response to
the Company Offer.

     No  member  of the  Board  and none of the  Company's  executive  officers,
affiliates or subsidiaries intends to tender or sell any Shares in the MPF Offer
or the Company Offer.

ITEM 5.  PERSON/ASSETS, RETAINED, EMPLOYED, COMPENSATED OR USED.

     Not applicable.

ITEM 6.  INTEREST IN SECURITIES OF THE SUBJECT COMPANY.

     Not applicable.

ITEM 7.  PURPOSES OF THE TRANSACTION AND PLANS OR PROPOSALS.

     Not applicable.

ITEM 8.  ADDITIONAL INFORMATION.

     The  information set forth in the Letter to the  Shareholders,  dated as of
October  1,  2007,  a copy of which is  attached  hereto as  Exhibit  (a)(1) and
incorporated herein by reference.

ITEM 9.  EXHIBITS.

        (a)(1)  Letter to Shareholders dated October 1, 2007.

        (e)      Not applicable.

        (g)      Not applicable.





                                    SIGNATURE

     After due inquiry  and to the best of my  knowledge  and belief,  I certify
that the information set forth in this statement is true, complete and correct.


Dated:   October 1, 2007                    BellaVista Capital, Inc


                                            /s/ MICHAEL RIDER
                                            -----------------------------
                                            Name:    Michael Rider
                                            Title:   President